Company news

China Resources Jiangzhong Pharmaceutical Co., Ltd. news in 2025

China Resources Jiangzhong Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Announcement on Resolutions of the 11th Meeting of the 10th Board of Directors

December 29, 2025

Announcement on Changing Company Name and Stock Abbreviation, Changing Registered Capital, Canceling Board of Supervisors, Amending the "Articles of Association" and Formulating and Revising Corporate Governance Systems

December 12, 2025

Announcement on Lifting of Sales Restrictions and Listing in the 3rd Lifting Period of Initially Granted Portion under the 2021 Restricted Stocks Incentive Plan

November 24, 2025

江中药业关于变更审计项目合伙人、签字会计师及质量控制复核人的公告

November 18, 2025

Announcement on Progress in Participating in the Establishment of Double-Crane Pharmaceutical Industry Investment Fund Phase II and Related Party Transactions

October 28, 2025

Announcement on the Implementation of Repurchase and Cancellation of Equity Incentive Restricted Stocks

October 27, 2025

Announcement on Resolutions of the 8th Meeting of the 10th Board of Supervisors

October 24, 2025

Announcement on Convening the Q3 2025 Performance Briefing

October 21, 2025

Announcement on Implementation of Semi-annual Dividend Distribution for 2025

September 26, 2025

Indicative Announcement on Equity Change of Controlling Shareholder and Its Persons Acting in Concert Reaching 1% Scale

September 18, 2025

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025

September 8, 2025

Announcement on Notifying Creditors of Repurchase and Cancellation of Partial Restricted Stocks

August 21, 2025

Announcement on Participating in the Establishment of Double-Crane Pharmaceutical Industry Investment Fund Phase II and Related Party Transactions

July 17, 2025

Announcement on Implementation of Dividend Distribution for 2024

June 13, 2025

Announcement on Results of Initial Granting under Phase II Restricted Stock Incentive Plan

June 9, 2025

Announcement on Lifting of Sales Restrictions and Listing in the 2nd Lifting Period of Reserved Granted Part under the 2021 Restricted Stocks Incentive Plan

May 26, 2025

Announcement on Attending the 2025 Online Collective Reception Day for Investors of Listed Companies in Jiangxi Jurisdiction

May 16, 2025

Board of Supervisors' Remarks on Publicity of and Verification Opinions on List of Incentive Objects Initially Granted in the 2nd Restricted Stock Incentive Plan

May 9, 2025

Notice on Convening the 2024 Annual General Meeting

April 25, 2025

Announcement on Obtaining Approval for Phase II Restricted Stock Incentive Plan

April 23, 2025

Announcement on Progress of Controlling Shareholder's Share Increase Plan

April 21, 2025

Indicative Announcement on Publication of 2024 Annual Performance Announcement by Indirect Holding Company China Resources Pharmaceutical Group Limited of Controlling Shareholder

March 26, 2025

Announcement on Using Idle Self-owned Funds to Purchase Wealth Management Products

March 19, 2025

Announcement on Preliminary Earnings Estimate for 2024

January 24, 2025

Summary Announcement on Phase II Restricted Stock Incentive Plan (Revised Draft)

January 1, 2025